Who is sponsoring NCT04003337?

NCT04003337 is sponsored by Procreatec.

What drugs are being tested in NCT04003337?

Interventions in NCT04003337: Morpho-kinetics selection with time-lapse (Embryoscope) evaluation.

What condition does NCT04003337 study?

NCT04003337 studies Embryo Implantation.

Is NCT04003337 still recruiting?

NCT04003337 is currently status unknown. Last updated 20 May 2020.

Last reviewed 2020-05-20 · How we verify

NCT04003337: EmbryoSEL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation.

Status unknown NA Last updated 20 May 2020

What this trial tests

NA trial testing Morpho-kinetics selection with time-lapse (Embryoscope) evaluation in Embryo Implantation in 228 participants. Status unknown.

Timeline

26 January 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Procreatec
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	228
Start date	26 January 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Spain

Drugs / interventions tested

Morpho-kinetics selection with time-lapse (Embryoscope) evaluation

Conditions studied

Embryo Implantation — all drugs for Embryo Implantation →

Sponsor

Procreatec

Who can join

Adults 18 to 50, female only, with Embryo Implantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our study intends to demonstrate that the selection of an embryo to transfer it at the sage of blastocyst through morphokinetics (analysis of embryos depending not only in their morphology -that is, the aspect of the embryo-, but also based on times of cell division) during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as selection is not performed in mere morphological evolution (visual aspect of the embryo) of the embryos.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Embryo Implantation

Currently open trials in the same condition.

NCT04721522 — The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome · recruiting

Other Procreatec trials

Trials by the same sponsor.

NCT03108157 — Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04003337 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Procreatec
Last refreshed: 20 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04003337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing